Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2019
Price : $35 *
At a glance
- Drugs Anakinra (Primary)
- Indications Haemochromatosis; Rheumatic disorders
- Focus Therapeutic Use
- Acronyms THERA
- 08 Mar 2019 Status changed from recruiting to discontinued.
- 31 Aug 2018 Biomarkers information updated
- 03 Jul 2017 Planned End Date changed from 1 Jan 2018 to 1 May 2019.